2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (10875):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W749742
    Isopropyltriphenylphosphonium bromide-13C3
    Isopropyltriphenylphosphonium bromide-13C3 (Triphenyl(propan-2-yl)phosphonium bromide-13C3) is the 13C-labeled Isopropyltriphenylphosphonium bromide (HY-W013757).
    Isopropyltriphenylphosphonium bromide-<sup>13</sup>C<sub>3</sub>
  • HY-W754400
    Mannosan,95%-13C6
    Mannosan,95%-13C6 (1,6-Anhydro-β-D-mannopyranose-13C6) is the 13C-labeled Mannosan,95% (HY-124095). Mannosan,95% (1,6-Anhydro-β-D-mannopyranose,95%) is a class of biochemical reagents used in glycobiology research. Glycobiology studies the structure, synthesis, biology, and evolution of sugars. It involves carbohydrate chemistry, enzymology of glycan formation and degradation, protein-glycan recognition, and the role of glycans in biological systems. This field is closely related to basic research, biomedicine, and biotechnology.
    Mannosan,95%-<sup>13</sup>C<sub>6</sub>
  • HY-Y0837S
    L-Alaninol-d3
    		98.0%
    L-Alaninol-d3 is the deuterium labeled L-Alaninol.
    L-Alaninol-d<sub>3</sub>
  • HY-133187S
    Blonanserin C-d8
    Blonanserin C-d8 is deuterium labeled Blonanserin C.
    Blonanserin C-d<sub>8</sub>
  • HY-132954S
    4-Fluorobenzaldehyde 2,4-dinitrophenylhydrazone-d3
    4-Fluorobenzaldehyde 2,4-dinitrophenylhydrazone-d3 is the deuterium labeled 4-Fluorobenzaldehyde 2,4-dinitrophenylhydrazone.
    4-Fluorobenzaldehyde 2,4-dinitrophenylhydrazone-d<sub>3</sub>
  • HY-W703929
    Hydroxy meprobamate-d4
    Hydroxy meprobamate-d4 is the deuterium labeled Hydroxy meprobamate.
    Hydroxy meprobamate-d<sub>4</sub>
  • HY-B0383AS
    Almotriptan hydrochloride-d6
    Almotriptan-d6 (PNU180638-d6) hydrochloride is the deuterium labeled Almotriptan hydrochloride. Almotriptan hydrochloride is an orally active, highly selective agonist of the 5-HT1B/1D receptor (5-HT1B/1D receptor), with EC50 values of 1.6 nM and 3.1 nM, respectively. Almotriptan hydrochloride shows moderate affinity for the 5-HT1F receptor, and weak affinity for the 5-HT1A, 5-HT6 and 5-HT7 receptors. Almotriptan hydrochloride induces intracranial vasoconstriction, inhibits nociceptive neurotransmission in the trigeminocervical complex, and suppresses the release of vasoactive peptides from trigeminal nerve endings. Almotriptan hydrochloride can be used in research related to migraine.
    Almotriptan hydrochloride-d<sub>6</sub>
  • HY-W726429
    Apomorphine hydrochloride-d4
    Apomorphine hydrochloride-d4 ((-)-Apomorphine hydrochloride-d4) is the deuterium labeled Apomorphine hydrochloride.
    Apomorphine hydrochloride-d<sub>4</sub>
  • HY-A0213AS
    Tiludronate-d5 sodium
    Tiludronate-d5 (sodium)mis the deuterium labeled Tiludronate disodium. Tiludronate (Tiludronic Acid) disodium, an orally active bisphosphonate, can act an osteoregulator. Tiludronate is used for the research of the metabolic bone disorders. Tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. Antiresorptive and anti-inflammatory properties.
    Tiludronate-d<sub>5</sub> sodium
  • HY-14885S
    Eliglustat-d15 tartrate
    Eliglustat-d15 (tartrate) is the deuterium labeled Eliglustat. Eliglustat tartrate is an specific, potent and orally active glucocerebroside synthase inhibitor with an IC50 of 24 nM.
    Eliglustat-d<sub>15</sub> tartrate
  • HY-75072S
    (Rac)-Bepotastine-d6
    (Rac)-Bepotastine-d6 is deuterium labeled 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid.
    (Rac)-Bepotastine-d<sub>6</sub>
  • HY-W769991
    Lactate sodium-13C2
    Lactic acid-13C2 (DL-Lactic acid-13C2) sodium is the 13C-labeled Lactic acid sodium . Lactic acid (DL-Lactic acid) sodium is a hydroxycarboxylic acid receptor 1 (HCAR1) activator and an epigenetic modulator inducing lysine residues lactylation. Lactic acid sodium is a glycolysis end-product, bridging the gap between glycolysis and oxidative phosphorylation. Lactic acid sodium is an oncometabolite and has immune protective role of lactate in anti-tumor immunity. Lactic acid sodium also has antimicrobial activity, which can be used as a food preservative.
    Lactate sodium-<sup>13</sup>C<sub>2</sub>
  • HY-W010112S
    4-Pentylphenol-d5
    4-Pentylphenol-d5 is the deuterium labeled 4-Pentylphenol.
    4-Pentylphenol-d<sub>5</sub>
  • HY-W751110
    N'-Nitro(methylsulfanyl)methanimidamide-13C
    N'-Nitro(methylsulfanyl)methanimidamide-13C (N-Nitro-S-methylisothiourea-13C) is the 13C-labeled N'-Nitro(methylsulfanyl)methanimidamide (HY-W673314).
    N'-Nitro(methylsulfanyl)methanimidamide-<sup>13</sup>C
  • HY-W750144
    Phenylglyoxylic acid-13C8
    Phenylglyoxylic acid-13C8 (Benzoylformic acid-13C8) is the 13C-labeled Phenylglyoxylic acid (HY-W010255). Phenylglyoxylic acid (Benzoylformic acid) is a metabolite of ethylbenzene and styrene (EB/S) and can be used as a biomarker of exposure to EB/S in human. Phenylglyoxylic acid can be used as drug intermediate for synthesis of antineoplastic compounds.
    Phenylglyoxylic acid-<sup>13</sup>C<sub>8</sub>
  • HY-W105111S
    1-Bromo-2,3,5-trichlorobenzene-d2
    1-Bromo-2,3,5-trichlorobenzene-d2 is the deuterium labeled 1-Bromo-2,3,5-trichlorobenzene.
    1-Bromo-2,3,5-trichlorobenzene-d<sub>2</sub>
  • HY-135331S
    N-Desmethyl-Apalutamide-15N,d4
    N-Desmethyl-Apalutamide-15N,d4 is the 15N and deuterium labeled isotope of N-Desmethyl-Apalutamide (HY-135331). N-Desmethyl Apalutamide is an active metabolite of Apalutamide. N-Desmethyl Apalutamide is a less potent antagonist of the androgen receptor and is responsible for one-third of the activity of Apalutamide. The formation of N-Desmethyl Apalutamide mediated predominantly by CYP2C8 and CYP3A4. N-Desmethyl Apalutamide is moderate to strong CYP3A4 and CYP2B6 inducer and has an excellent plasma-proteins bound concentration.
    N-Desmethyl-Apalutamide-<sup>15</sup>N,d<sub>4</sub>
  • HY-13256AS1
    Desmethyl Erlotinib-d4-1
    Desmethyl Erlotinib-d4-1 (OSI-420-d4-1 (free base); CP-373420-d4-1) is deuterium-labeled Desmethyl Erlotinib (HY-13256A).
    Desmethyl Erlotinib-d<sub>4</sub>-1
  • HY-W711307
    2-Acetamidobutanoic acid-d5
    2-Acetamidobutanoic acid-d5 (2-Acetamidobutyric acid-d5) is the deuterium labeled 2-Acetamidobutanoic acid (HY-W077293).
    2-Acetamidobutanoic acid-d<sub>5</sub>
  • HY-166900S
    3,3′,4,5′-Tetrabromodiphenyl ether-13C12
    3,3′,4,5′-Tetrabromodiphenyl ether-13C12 is 13C labeled 3,3′,4,5′-Tetrabromodiphenyl ether.
    3,3′,4,5′-Tetrabromodiphenyl ether-<sup>13</sup>C<sub>12</sub>